ilmscore | Prediction Details
"The company is a best-in-class pharmaceutical with a strong pipeline across every phase of Trials which is going to keep that Revenue growing."
By Let's Talk Money! with Joseph Hogue, CFA | April 10, 2024 | Pending
From video
7 Dividend Kings for a Bullet-Proof Portfolio in 2024 00:09:20 - 00:09:25
Interpreted Prediction
AbbVie's strong drug pipeline is predicted to sustain its revenue growth.

Prediction Details

Ticker
ABBV

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.